{"text_format":"3","workbook":"xlsx","n_sheets":1,"sheets":["Sheet1"],"read":"whole","date_system":"1900"}

{"sheet":"Sheet1","index":0,"n_rows":60,"n_cols":3,"rows_kept":60,"merged":[[0,0,0,2]]}
["Table1 Summary of clinical information for patients with LAUD"]
["Variables","Case","Percentage"]
["Gender"]
["Male",242,{"$f":"B4/522","v":{"v":0.46360153256704983,"d":"46.36%"}}]
["Female",280,{"$f":"B5/522","v":{"v":0.5363984674329502,"d":"53.64%"}}]
["Age (years)"]
["Range","33-88"]
["Median",66]
["Race"]
["ASIAN",8,{"$f":"B10/522","v":{"v":0.01532567049808429,"d":"1.53%"}}]
["BLACK ",53,{"v":0.10153256704980843,"d":"10.15%"}]
["AMERICAN INDIAN",1,{"v":1.9157088122605363E-3,"d":"0.19%"}]
["WHITE",393,{"v":0.7528735632183908,"d":"75.29%"}]
["unknow",67,{"v":0.12835249042145594,"d":"12.84%"}]
["clinical Stage"]
["Stage I",279,{"v":0.5344827586206896,"d":"53.45%"}]
["Stage II",124,{"v":0.23754789272030652,"d":"23.75%"}]
["Stage III",85,{"v":0.16283524904214558,"d":"16.28%"}]
["Stage IV",26,{"v":0.04980842911877394,"d":"4.98%"}]
["unknow",8,{"v":0.01532567049808429,"d":"1.53%"}]
["T stage"]
["T1+Tis",172,{"v":0.32950191570881227,"d":"32.95%"}]
["T2",281,{"v":0.5383141762452107,"d":"53.83%"}]
["T3",47,{"v":0.09003831417624521,"d":"9.00%"}]
["T4",19,{"v":0.03639846743295019,"d":"3.64%"}]
["Tx",3,{"v":0.005747126436781609,"d":"0.57%"}]
["Lymph node status"]
["N0",335,{"v":0.6417624521072797,"d":"64.18%"}]
["N1",98,{"v":0.18773946360153257,"d":"18.77%"}]
["N2",75,{"v":0.14367816091954022,"d":"14.37%"}]
["N3",2,{"v":3.8314176245210726E-3,"d":"0.38%"}]
["Nx+unknow",12,{"v":0.022988505747126436,"d":"2.30%"}]
["Metastatic"]
["M0",353,{"v":0.6762452107279694,"d":"67.62%"}]
["M1",25,{"v":0.04789272030651341,"d":"4.79%"}]
["Mx+unknow",144,{"v":0.27586206896551724,"d":"27.59%"}]
["Eml4-Alk translocation status"]
["Yes",34,{"v":0.06513409961685823,"d":"6.51%"}]
["No",213,{"v":0.40804597701149425,"d":"40.80%"}]
["unknow",275,{"v":0.5268199233716475,"d":"52.68%"}]
["EGFR mutation status"]
["Yes",80,{"v":0.1532567049808429,"d":"15.33%"}]
["NO",197,{"v":0.3773946360153257,"d":"37.74%"}]
["unknow",285,{"v":0.5459770114942529,"d":"54.60%"}]
["KRAS mutation status"]
["Yes",62,{"v":0.11877394636015326,"d":"11.88%"}]
["No",253,{"v":0.4846743295019157,"d":"48.47%"}]
["unknow",207,{"v":0.39655172413793105,"d":"39.66%"}]
["Postoperative tumor status"]
["WITH TUMOR",111,{"v":0.21264367816091953,"d":"21.26%"}]
["TUMOR FREE",314,{"v":0.6015325670498084,"d":"60.15%"}]
["unknow",97,{"v":0.18582375478927204,"d":"18.58%"}]
["ECOG"]
[0,95,{"v":0.18199233716475097,"d":"18.20%"}]
["2021-01-03",124,{"v":0.23754789272030652,"d":"23.75%"}]
["unknow",303,{"v":0.5804597701149425,"d":"58.05%"}]
["History neoadjuvant treatment"]
["Yes",3,{"v":0.005747126436781609,"d":"0.57%"}]
["No",518,{"v":0.9923371647509579,"d":"99.23%"}]
["unknow",1,{"v":1.9157088122605363E-3,"d":"0.19%"}]